The latest news from Arcinova
June 1, 2020
Register now for Arcinova's webinar - Preformulation to first in human: avoiding pitfalls for early clinical success
Register now for Arcinova's webinar - Preformulation to first in human: avoiding pitfalls for early clinical success Preformulation characterization of new chemical entities (NCE) can be c
June 1, 2020
Paul Quigley joins advisory board of the Leeds’ EPSRC Centre for Doctoral Training in Molecules to Product
We are thrilled to announce that our Head of Drug Substance, Paul Quigley, has been invited to join the advisory board of the Leeds’ EPSRC Centre for Doctoral Training in Molecules to Product.
April 2, 2020
Arcinova wins BVCA Yorkshire and North East business awards - Business Transformation Management Team
Exciting news - we have won the Business Transformation Management Team title at the British Private Equity & Venture Capital Association (BVCA)’s Yorkshire and North East Management Team Aw
April 1, 2020
Arcinova’s Senior Director of Business Development Europe named 2020 Northern Powerhouse Export Champion
Arcinova, a multi-service Contract Development and Manufacturing Organisation (CDMO) based in Northumberland, England, is delighted to announce that its Senior Director of Business Development Eur
March 2, 2020
Fantastic news - we are the highest-placed CDMO on Alantra's #PharmaFast50!
Fantastic news - we are the highest-placed CDMO on Alantra's #PharmaFast50! We are delighted by this recognition of our work as a North East-based CDMO that serves the global Pharma indust
January 31, 2020
Arcinova Releases Latest Case Study - Capsule Product Manufacturing
The challenge - Accelerate first-in-human and Phase II trials for an oral dosage form intended for treatment of CNS disorders. A fully integrated approach was required, to include drug substance m
January 27, 2020
Arcinova Launches Latest Video
Have you ever wondered what our site looks like? View our video here
January 24, 2020
Arcinova Releases Latest Case Study - Precision Filling
The challenge - To rapidly manufacture a GMP-compliant API-in-capsule product for use in Phase I and Phase II clinical trials. The product was being investigated for treatments spanning mult
January 24, 2020
2020 Britest Process Understanding Day
This week Rory MacDonald was delighted to attend the 2020 Britest Process Understanding Day to present on how Arcinova has been making use of Britest tools to help capture knowledge and perform teDiscover how Arcinova can help
We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.
